Online Only Articles

Thrombospondin-1 inhibits ADAMTS13 activity in sickle cell disease

Vascular Medicine Institute, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA
Sickle Cell Vascular Disease Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
Critical Care Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA
Vascular Medicine Institute, Division of Pulmonary, Allergy, Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA
ITXM-Diagnostics, Pittsburgh, PA, USA
Sickle Cell Vascular Disease Section, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD, USA
ITXM-Diagnostics, Pittsburgh, PA, USA
Vascular Medicine Institute, Division of Hematology/Oncology, University of Pittsburgh, Pittsburgh, PA, USA
Vascular Medicine Institute, Division of Pulmonary, Allergy, Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Vascular Medicine Institute, Division of Pulmonary, Allergy, Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA, USA
Vol. 98 No. 11 (2013): November, 2013 https://doi.org/10.3324/haematol.2013.092635